SPACE, RF ablation combo safe and effective for lung cancer

SPACE, RF ablation combo safe and effective for lung cancer
For unresectable lung tumors, the combination of segmental pulmonary arterial chemoembolization and percutaneous radiofrequency ablation helps achieve better local tumor progression rates than radiofrequency ablation alone, according to a study published in the May issue of Radiology.

(HealthDay)—For unresectable lung tumors, the combination of segmental pulmonary arterial chemoembolization (SPACE) and percutaneous radiofrequency (RF) ablation helps achieve better local tumor progression rates than RF ablation alone, according to a study published in the May issue of Radiology.

Cosmo D. Gadaleta, M.D., from the National Cancer Research Centre Istituto Tumori Giovanni Paolo II Bari in Italy, and colleagues treated 20 nodules over 19 sessions in 17 patients with primary and metastatic lung cancer. SPACE was performed, followed by percutaneous computed tomography (CT)-guided RF ablation of 48 hours later. Enhanced CT was performed 48 hours after combination, after 30 days, and then every three months. Three months after combination therapy and then every six months, fluorine 18 fluorodeoxyglucose positron emission tomography was performed.

The researchers found that in the lung parenchyma treated with SPACE there was a wide area without ventilation seen with ventilation-lung single CT. In 3- to 5-cm-diameter tumors, the local (LTP) rate was 21 percent (three of 14 nodules), and the LTP was 0 percent (zero of six nodules) in tumors of 3 cm or smaller in diameter. In 65 percent of patients, complete response was seen at a minimum of six months of follow-up. Pneumothorax occurred in five of 19 sessions (26 percent), as did one bronchopleural fistula (one of 19; 5 percent).

"Combination therapy with RF ablation after SPACE to treat unresectable is technically feasible, safe, and effective and may represent an advantage over RF ablation alone," the authors write.

One author disclosed to Angiodynamics.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

R.E.N.A.L. nephrometry score predicts treatment efficacy

date Dec 27, 2012

(HealthDay)—The R.E.N.A.L. (radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior and location relative to polar lines) nephrometry scoring system predicts the efficacy ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

date Jul 03, 2015

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

date Jul 02, 2015

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

date Jul 02, 2015

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.